Correlation of the horizontal abundance of the intestinal microbiota genus with the pharmacokinetic parameters of n-butylphthalide and the expression of CYP3A1. by Xiangchen Li (512737)

Subjects:

S1 Data - by Xiangchen Li (512737)

Subjects:

Characterization of passage 1 (P1) bone marrow-derived canine mesenchymal stromal cells (cMSCs). by Melissa A. MacIver (12850566)

Subjects:

Effects of the intestinal microbiota on metabolic pathways. by Xiangchen Li (512737)

Subjects:

S1 File - by Xiangchen Li (512737)

Subjects:

TUNEL staining. by Melissa A. MacIver (12850566)

Subjects:

Safranin O and toluidine blue histology. by Melissa A. MacIver (12850566)

Subjects:

Experimental outline. by Melissa A. MacIver (12850566)

Subjects:

Cytotoxicity and total glycosaminoglycan (GAG) content. by Melissa A. MacIver (12850566)

Subjects:

Gross photography and construct weight for initial chondrogenic screening. by Melissa A. MacIver (12850566)

Subjects:

The CYP3A1mRNA and protein expressions in the small intestine and the liver (n = 3). by Xiangchen Li (512737)

Subjects:

Mechanically- and starvation-induced activity. by Jiangtian Chen (3186810)

“…Thermogenetic activation of AstA cells in <i>AstA</i>^<i>34</i>><i>TrpA1</i> flies resulted in decreased average velocity <b>(A)</b> and a shorter distance walked <b>(B)</b> in a 2 min window after each stimulus compared to controls (n = 5). …”

Patient characteristics of individuals referred to or evaluated by a cystic fibrosis-gastrointestinal clinic. by Nicha Wongjarupong (4671181)

Norm ISWSVR: A Data Integration and Normalization Approach for Large-Scale Metabolomics by Xian Ding (421647)

“…More importantly, Norm ISWSVR also allows a low frequency of QCs, which could significantly decrease the burden of a large-scale experiment. …”

Data_Sheet_1_Versatile Role of Rab27a in Glioma: Effects on Release of Extracellular Vesicles, Cell Viability, and Tumor Progression.PDF by Thomas S. van Solinge (9637007)

“…</p><p>Results: Knockdown of Rab27a in GL261 glioma cells decreased the release of small EVs isolated at 100,000 × g in vitro (p = 0.005), but not the release of larger EVs, isolated at 10,000 × g. …”

Eligibility criteria. by Michel Mandro (2637532)

Subjects:

The frequency of adverse events in both treatment arms. by Michel Mandro (2637532)

Subjects:

Evolution of the probability of being seizure-free in both treatment arms over time. by Michel Mandro (2637532)

Subjects:

Multiple logistic regression exploring the association between the treatment arms and being seizure-free at month 4. by Michel Mandro (2637532)

Subjects:

Multiple logistic regression model exploring factors associated with >50% seizures reduction at month 4. by Michel Mandro (2637532)

Subjects: